Rajal B. Shah

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	26793	5971
h-endeksi	73	37
i10-endeksi	135	95

2000

1000

500

1500

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025139 192 294 324 502 746 1284 1299 1489 1659 1754 1953 1836 1649 1514 1406 1256 1242 1290 1257 1255 966 987 194

Genel erişim

Tümünü görüntüle

24 makale

2 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Mark A RubinProfessor & Director Department for BioMedical Research, University of Berndbmr.unibe.ch üzerinde doğrulanmış e-posta adresine sahip
Scott TomlinsAssociate Professor of Pathology and Urologyumich.edu üzerinde doğrulanmış e-posta adresine sahip
Kenneth PientaProfessor of Urology, Oncology, Pharmacology and Molecular Sciences, Johns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Ming ZhouTufts Medical Centerutsouthwestern.edu üzerinde doğrulanmış e-posta adresine sahip
Saravana M DhanasekaranResearch Scientistumich.edu üzerinde doğrulanmış e-posta adresine sahip
Debashis GhoshProfessor, Colorado School of Public Healthucdenver.edu üzerinde doğrulanmış e-posta adresine sahip
Daniel RhodesUniversity of Michigan, Compendia Bioscience, Life Technologieslifetech.com üzerinde doğrulanmış e-posta adresine sahip
Ronglai ShenMemorial Sloan-Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip
Sven PernerPathology, UKSH Campus Luebeck and Research Center Borsteluksh.de üzerinde doğrulanmış e-posta adresine sahip
Liang Cheng, MDIndiana University School of Medicine, Indianapolis, USAiupui.edu üzerinde doğrulanmış e-posta adresine sahip
Nallasivam Palanisamy, M.Sc., M.Phil.,...Asso.Prof.Henry Ford Health; Asso. Prof. Michigan State Univ.hfhs.org üzerinde doğrulanmış e-posta adresine sahip
Martin G SandaProfessor and Chairman of Urology, Emory University School of Medicineemory.edu üzerinde doğrulanmış e-posta adresine sahip
Mahul B. AminUniversity of Tennessee Health Science Center; University of Southern Californiauthsc.edu üzerinde doğrulanmış e-posta adresine sahip
Chandan Kumar-SinhaUniversity of Michiganumich.edu üzerinde doğrulanmış e-posta adresine sahip
guido martignoniUniversity of Veronaunivr.it üzerinde doğrulanmış e-posta adresine sahip

Takip et

Rajal B. Shah

Dr. Charles T. Ashworth Professor of Pathology, University of Texas Southwestern Medical Center

utsouthwestern.edu üzerinde doğrulanmış e-posta adresine sahip

Urologic Pathology Urologic Oncology Prostate cancer Molecular biology Biomarkers


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005	4907	2005
Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001	2148	2001
Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007	1092	2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007	1008	2007
Role of the TMPRSS2-ERG gene fusion in prostate cancer SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ... Neoplasia 10 (2), 177-IN9, 2008	914	2008
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005	902	2005
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ... Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008	848	2008
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004	747	2004
TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ... Cancer research 66 (7), 3396-3400, 2006	588	2006
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression S Perner, MD Hofer, R Kim, RB Shah, H Li, P Möller, RE Hautmann, ... Human pathology 38 (5), 696-701, 2007	576	2007
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ... Cancer research 67 (22), 10657-10663, 2007	418	2007
The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008	400	2008
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer R Mehra, SA Tomlins, R Shen, O Nadeem, L Wang, JT Wei, KJ Pienta, ... Modern Pathology 20 (5), 538-544, 2007	378	2007
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer R Mehra, SA Tomlins, J Yu, X Cao, L Wang, A Menon, MA Rubin, ... Cancer research 68 (10), 3584-3590, 2008	339	2008
Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity S Gobbo, JN Eble, DJ Grignon, G Martignoni, GT MacLennan, RB Shah, ... The American journal of surgical pathology 32 (8), 1239-1245, 2008	336	2008
Noninvasive detection of TMPRSS2: ERG fusion transcripts in the urine of men with prostate cancer B Laxman, SA Tomlins, R Mehra, DS Morris, L Wang, BE Helgeson, ... Neoplasia 8 (10), 885-888, 2006	325	2006
Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer RB Shah, M Zhou, M LeBlanc, M Snyder, MA Rubin The American journal of surgical pathology 26 (9), 1161-1168, 2002	311	2002
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States JM Mosquera, R Mehra, MM Regan, S Perner, EM Genega, G Bueti, ... Clinical cancer research 15 (14), 4706-4711, 2009	294	2009
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications JM Mosquera, S Perner, EM Genega, M Sanda, MD Hofer, KD Mertz, ... Clinical Cancer Research 14 (11), 3380-3385, 2008	290	2008
Integrative genomics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer J Yu, Q Cao, R Mehra, B Laxman, J Yu, SA Tomlins, CJ Creighton, ... Cancer cell 12 (5), 419-431, 2007	282	2007

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar